U.S. Health Regulators Call for Pause of J&J Vaccine Over Possible Rare Blood Clotting Risk
Health regulators in the U.S. are calling for the Johnson & Johnson covid-19 vaccine to be temporarily suspended from use, following a small number of reports of a possible link between the vaccine and severe blood clotting. The potential added risk appears to be very rare, and no such connection has been documented...